Discussion
In a representative sample of Hispanics/Latinos, chronic exposure to SHS was associated with changes in cardiac structure along with systolic and diastolic functions. Chronic SHS exposure in childhood only was associated with worse LV diastolic function, while chronic SHS exposure in adolescence/adulthood only was associated with increased left atrial size and shorter IVRT signalling reduced LV compliance causing a rapid increase in LV intracardiac pressures with early cessation of LV filling. Chronic SHS exposure in adolescence/adulthood was also paradoxically increased LVEF possibly as a means of compensation to maintain cardiac output in the setting of abnormal diastolic function. Chronic SHS exposure in both childhood and adolescence/adulthood was associated with decreased myocardial deformation consistent with a pattern seen in early heart failure with preserved ejection fraction (HFpEF) where there is abnormal diastolic function, normal systolic function but abnormal myocardial deformation mechanics.22 Current SHS exposure from living with a tobacco smoker was associated with decreased LV systolic function as measured by ejection fraction and global longitudinal strain.
To our knowledge, this study represents one of the first studies to examine the relationship of chronic SHS exposure with cardiac structure and function. The results of this study contribute to the emerging body of evidence regarding the adverse effects of exposure to tobacco smoke on cardiac structure and function, which has primarily been studied in active current smokers. Within Echo-SOL, increased pack-years of tobacco smoking was associated with decreased systolic and diastolic function and increased cigarettes smoked per day were associated with increased LV mass.23 A study of the Coronary Artery Risk Development in Young Adults (CARDIA) cohort found that tobacco smoking was associated with a trend towards increased LV mass in all groups except for African-American men and increased LV stress in women; however, the echocardiographic variables in this study were limited to linear measurements, and 2D quantitation was not performed.24 In Multi-Ethnic Study of Atherosclerosis (MESA), a dose–response relationship between cigarette consumption measured in pack-years and regional LV dysfunction was noted.25 Furthermore, a controlled experiment of the acute response to active tobacco smoking demonstrated immediate impairment in multiple measures of diastolic function.26 However, the data from our study support that notion that even passive SHS is associated with alterations LV systolic function and diastolic function.
The mechanisms by which tobacco smoke exposure impacts myocardial function are not well described, although exposure to SHS has been associated with increased serum homocysteine and fibrinogen levels, which are associated with increased inflammation and thrombosis.27 Experimental and clinical studies have shown the direct toxic effects of cigarette smoke on the myocardium, including abnormalities in energy metabolism, lipotoxicity and oxidative stress.28 29 Additionally, animal models suggest that chronic exposure to tobacco smoke increases blood pressure and oxidative stress and causes endothelial dysfunction.30 Of note, in our study, current exposure to a household smoker was associated with more profound decreases in systolic and diastolic function than any other measure of chronic SHS smoke exposure. Yet, in the absence of current exposure to SHS, chronic SHS exposure in childhood was still associated with decrease diastolic function, thus highlighting the potential long-term impact of remote SHS exposure on cardiac function. In utero exposure to maternal and paternal smoking has been found to increase the risk of decreased cardiac function in children.31–34 In our study, it is difficult to determine whether participants that report childhood exposure to SHS were also exposed in utero and thus separate the cardiac effects of in utero exposure from childhood SHS exposure. However, these findings are hypothesis generating and highlight the potential impact of childhood environmental exposures on future cardiac health in adulthood.
The observed relationship between SHS exposure and cardiac function has implications for public health strategies for primordial prevention of heart failure, particularly in Hispanics/Latinos. During 2011–2012, about 58 million non-smokers in the USA were exposed to SHS; with two out of every five children—including 7 out of every 10 black children—being exposed to SHS regularly.17 Racial and ethnic differences in LV mass, diastolic function, systolic function and myocardial deformation are not completely explained by cardiometabolic risk factors and comorbidities.35 Within Echo-SOL, the average values of LV size and mass are different than what has been reported in non-Hispanic white cohorts of healthy participants.36 Additionally, LV diastolic dysfunction is more highly prevalent in Hispanics/Latinos than in cohorts of non-Hispanic whites.37 Similar differences have been observed in reference values for global longitudinal strain in healthy African-Americans when compared with healthy whites in the CARDIA study.38 The degree to which intervenable environmental exposures, such as household exposure to SHS, might contribute to racial/ethnic differences in cardiac function, and thus future heart failure risk, is an important consideration.39
This study has several limitations. First, SHS exposure was assessed by self-report and thus is subject to recall bias. Second, considerable heterogeneity in SHS exposure intensity for each measure of SHS likely exists. Serum cotinine levels were not measured to quantitatively assess current SHS exposure and assess for dose response. Third, the cross-sectional design of this observational study limits our ability to determine causality. We acknowledge that we did not account for multiple testing. However, most of our findings are at the p value less than the 0.01 level. SHS is conceptualised as a form of indoor air pollution,40 placing hypertension, obesity and diabetes41 on the causal pathway of our cardiac outcomes and thus justifying their exlusion fromour statistical models as confounders. Finally, the sample size of Echo-SOL is modest, limiting statistical power and type II error. Future studies of SHS and cardiac function with a larger sample and a longitudinal design are needed to better assess cardiac function and clinical heart failure outcomes.